UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007204
Receipt number R000008480
Scientific Title A study on the aggravation prophylaxis of postoperative delirium for the elderly
Date of disclosure of the study information 2012/02/02
Last modified on 2016/08/08 08:26:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the aggravation prophylaxis of postoperative delirium for the elderly

Acronym

A study on the aggravation prophylaxis of postoperative delirium for the elderly

Scientific Title

A study on the aggravation prophylaxis of postoperative delirium for the elderly

Scientific Title:Acronym

A study on the aggravation prophylaxis of postoperative delirium for the elderly

Region

Japan


Condition

Condition

postoperative delirium

Classification by specialty

Surgery in general Psychiatry Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this RCT study is to make it clear whether Haloperidol administration from an early stage of delirium is useful for the aggravation prevention of postoperative delirium of the elderly persons more than 75 years old.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We chase psychological disorders / abnormal behavior assessment with NEECHAM score from preoperative day to postoperative day 10 consecutively.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

In the intervention group, Haloperidol 5mg intravenous drip infusion will be performed from postoperative day 0 to 5, when the NEECHAM score is 20 to 24.
When the NEECHAM score is less than 19, conventional treatment of delirium including the haloperidol intravenous drip infusion will be performed.

Interventions/Control_2

Only serial obsevations will be applied to the control group.
When the NEECHAM score is less than 19, conventional treatment of delirium including the haloperidol intravenous drip infusion will be performed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

75 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

75 years or older patients with abdominal surgery / orthopedic surgery are distributed to the intervention / non-intervention group.

Key exclusion criteria

A patient with emergency surgery.
The case whose NEECHAM score is less than 19.

Target sample size

180


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinji Fukata

Organization

National Center for Geriatrics and Gerontology

Division name

Department of Perioperative Medical Care

Zip code


Address

Gengo 35, Morioka-cho, Obu-city, Aichi, Japan

TEL

0562-46-2311

Email

fukatash@ncgg.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinji Fukata

Organization

National Center for Geriatrics and Gerontology

Division name

Department of Perioperative Medical Care

Zip code


Address

Gengo 35, Morioka-cho, Obu-city, Aichi, Japan

TEL

0562-46-2311

Homepage URL


Email

fukatash@ncgg.go.jp


Sponsor or person

Institute

National Center for Geriatrics and Gerontology

Institute

Department

Personal name



Funding Source

Organization

National Center for Geriatrics and Gerontology(Independent administative agency)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 01 Month 31 Day

Date of IRB


Anticipated trial start date

2012 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 02 Month 02 Day

Last modified on

2016 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008480


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name